Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 18;1(1):44.
doi: 10.1186/1757-1626-1-44.

Sulfamethoxazole/Trimethoprim induced liver failure: a case report

Salaheldin Abusin  1 , Swapna Johnson
Affiliations

Sulfamethoxazole/Trimethoprim induced liver failure: a case report

Salaheldin Abusin et al. Cases J. .

Abstract

Sulfamethoxazole/Trimethoprim (SMX/TMP) is a commonly used antibiotic, its' known adverse reaction of hepatotoxicity leading to acute liver failure is considered rare. We present a case of a 22 year old female who developed jaundice and acute liver failure one week after taking SMX/TMP for a UTI. After an extensive work up, a clinical diagnosis of SMX/TMP induced liver failure was reached. Over the course of several weeks she made a good clinical and biochemical recovery with supportive care. In this case report we describe her clinical presentation and course, and present a brief review of the literature.

PubMed Disclaimer

References

    1. Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis. 39:75–80. doi: 10.1086/422145. 2004 Jul 1. - DOI - PubMed
    1. Ransohoff DF, Jacobs G. Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. Gastroenterology. 1981;80:816–819. - PubMed
    1. Abi Mansur P, Ardiaca MC, Allam C, Shammaia M. Trimethoprim-sulfamethoxazole induced cholestasis. Am J Gastroenterol. 1981;76:356–359. - PubMed
    1. Yao F, Behling CA, Saab S, Li S, Hart M, Lyche KD. trimethoprim-sulfamethoxazole induced vanishing bile duct syndrome. Am J Gastroenterology. 1997;92:167–169. - PubMed
    1. Altraif I, Lilly L, Wanless IR, Heathcote J. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. Am J Gastroenterol. 1994;89:1230–4. - PubMed

LinkOut - more resources